Inventor · disambiguated record
Richard Lowenthal
Also filed as: LOWENTHAL RICHARD · LOWENTHAL RICHARD E
9 granted patents·3 pending applications·196 citations·filing 1987–2025
89Inventor score
Files withAEGIS THERAPEUTICS LLC7ARS PHARMACEUTICALS OPERATIONS INC1LOWENTHAL RICHARD1MASSACHUSETTS INST TECHNOLOGY1MOMOTARO GENE INC1
Top patents by PatentIndex Score
12 records- 0198US4876399ATaxols, their preparation and intermediates thereofRES CORP TECHNOLOGIES INC·Filed 1987·Granted Oct 24, 1989·147 cites·3 claims
- 0297US11918655B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2023·Granted Mar 5, 2024·5 cites·44 claims
- 0397US11717571B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2022·Granted Aug 8, 2023·6 cites·30 claims
- 0497US11191838B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2020·Granted Dec 7, 2021·8 cites·20 claims
- 0596US12324838B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2023·Granted Jun 10, 2025·3 cites·11 claims
- 0696US11744895B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2021·Granted Sep 5, 2023·3 cites·26 claims
- 0796US10682414B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2019·Granted Jun 16, 2020·10 cites·20 claims
- 0883US2025262305A1Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 0979US11484592B2Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitorMOMOTARO GENE INC·Filed 2017·Granted Nov 1, 2022·2 cites·2 claims
- 1067US5298623ACu complexes of bis-oxazolines and their useMASSACHUSETTS INST TECHNOLOGY·Filed 1991·Granted Mar 29, 1994·12 cites·12 claims
- 1164US2023279432A1Engineered adenovirus vectors and uses thereofLOWENTHAL RICHARD·Filed 2022·Application pending·0 cites
- 1250US2025262173A1Intranasal epinephrine formulations and methods of useARS PHARMACEUTICALS OPERATIONS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Lowenthal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →